Menu

G-Protein Receptor Work Wins Nobel

Robert J. Lefkowitz and Brian K. Kobilka take this year’s Nobel Prize for Chemistry for revealing the receptors through which cells sense their environment.

Oct 10, 2012
Dan Cossins

Wikimedia Commons, ValerynsThe 2012 Nobel Prize for Chemistry goes to Robert J. Lefkowitz of Duke University and Brian K. Kobilka of Stanford University for their work in discovering the inner workings of G-protein-coupled receptors, which enable cells to sense their environment and communicate with each other, the Nobel Assembly at Karolinska Institute announced this morning (October 10) from Stockholm. 

Lefkowitz started to trace cell receptors in 1968. Using radioactivity, he managed to unveil several receptors, including one for adrenalin, the β-adrenergic receptor. His team then extracted the receptor from the cell membrane and forged an initial understanding of how it works.

In the 1980s, Kobilka, then a postdoc at Duke, isolated the gene that codes for the β-adrenergic receptor, and found that the receptor was similar to one in the eye that captures light. They also realized that the β-adrenergic receptor was one of many in a whole family of receptors that function in the same way.

This family is now known as G-protein-coupled receptors, and the studies by Lefkowitz and Kobilka have been crucial to understanding how they function. The insights have been critical to drug discovery, among other areas of research, as around half of all drugs currently available work by targeting these receptors. 

 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.